Towards a reliable parameter of liver damage in hepatitis C: TUNEL versus caspase activation
Young S. Hahn, Carolina Soguero, Michael Cruise – 30 December 2003
Young S. Hahn, Carolina Soguero, Michael Cruise – 30 December 2003
Mark A. Ross, Christina M. Sander, Talia B. Kleeb, Simon C. Watkins, Donna Beer Stolz – 30 December 2003 – Regenerating liver was evaluated for the spatiotemporal expression of angiogenic growth factor receptors on endothelial cell (EC) membranes during revascularization resulting from 70% partial hepatectomy (PHx). Fractions enriched in EC membranes were examined by Western blot for angiogenic growth factor receptor expression from 1 to 14 days after PHx.
Harvey J. Alter – 30 December 2003
Adrian Reuben – 30 December 2003
E. Anthony Jones, Cristina Lavini – 30 December 2003
Takeo Shimazaki, Masao Honda, Shuichi Kaneko, Kenichi Kobayashi – 30 December 2003 – Translation of the hepatitis C virus (HCV) polyprotein is mediated by an internal ribosome entry site (IRES) that is located within the 5′‐nontranslated region (5′NTR). We investigated the effect of interferon alfa (IFN‐α) on the IRES‐directed translation of HCV, using two stably transformed cell lines, RCF‐1 and RCF‐26, of Huh7 cells derived from human hepatocellular carcinoma that express dicistronic reporter proteins, Renilla luciferase (RL) and firefly luciferase (FL), separated by HCV‐IRES.
Christophe Corpechot, Raoul Poupon – 30 December 2003
Aaron Ciechanover, Alan L. Schwartz – 30 December 2003
Johannes Herkel, Birgit Heidrich, Nicole Nieraad, Ingrid Wies, Michael Rother, Ansgar W. Lohse – 30 December 2003 – Autoantibodies to soluble liver antigen and liver pancreas (SLA/LP) have been described as specific markers for Autoimmune Hepatitis (AIH), occurring in about 20% of patients with AIH. The high degree of specificity for SLA/LP in autoimmune liver disease suggests a possible role in its pathogenesis. This study aims to map the exact epitope(s) recognized by SLA/LP autoantibodies and to assess the role of molecular mimicry between microbial antigens and self‐epitopes.
Aldo D. Mottino, Jingsong Cao, Luis M. Veggi, Fernando Crocenzi, Marcelo G. Roma, Mary Vore – 30 December 2003 – Estradiol‐17β‐D‐glucuronide (E217G), an endogenous metabolite of estradiol, induces a potent dose‐dependent and reversible inhibition of bile flow in the rat. We analyzed the effect of a single dose of E217G (15 μmol/kg, intravenously) to female rats on bile flow and the endocytic retrieval and function of the canalicular multidrug resistance‐associated protein 2 (Mrp2) and the effect of pretreatment with dibutyryl‐cyclic AMP (DBcAMP; 20 μmol/kg) on these measures.